A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 22, 2022
Source ID
10.1172/jci.insight.162553

Entities

People

  • Abhijeet J. Kulkarni
  • Alfredo Perales-Puchalt
  • Daniel H. Park
  • Daniel W Kulp
  • David B. Weiner
  • Devivasha Bordoloi
  • Kevin Liaw
  • Pratik S Bhojnagarwala
  • Rugang Zhang
  • Ryan P. O’connell
  • Xizhou Zhu

Organizations

  • United States Department of Defense

Tags

Technology Areas

  • Biotechnology
  • Biotechnology - Cancer Biotech